Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1977;55:660-661

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steele, P.
Right arrow Articles by Genton, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steele, P.
Right arrow Articles by Genton, E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*OXYGEN
*SULFINPYRAZONE
Medline Plus Health Information
*Pulmonary Hypertension

Circulation, Vol 55, 660-661, Copyright © 1977 by American Heart Association


ARTICLES

Platelet survival time in patients with hypoxemia and pulmonary hypertension

P Steele, JH Ellis Jr, HS Weily and E Genton

Platelet survival time (autologous labeling with 51chromium) was measured in 63 patients in order to evaluate the role of platelets in the thromboembolic complications of patients with hypoxemia and pulmonary hypertension. Thirty-eight of these patients had chronic obstructive airways disease; 13, primary pulmonary hypertension; seven, recurrent pulmonary embolism; four, the Eisenmenger syndrome; and one, multiple pulmonary arteriovenous fistula. Forty-three patients were hypeakly associated with arterial oxygen tension ( r = 0.50), but not with the arterial carbon dioxide tension or the level of pulmonary artery pressure. Sulfinpyrazone lengthened platelet survival in 12 of 24 (50%) treated patients but this drug did not alter either arterial oxygen tension arterial carbon dioxide tension, or pulmonary artery pressure. Our results suggest that hypoxemia is associated with shortened platelet survival time and that platelets may, therefore, be involved in the thromboembolic complications that develop in patients with hypoxemia.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
C. K. Silversides, J. T. Granton, E. Konen, M. A. Hart, G. D. Webb, and J. Therrien
Pulmonary thrombosis in adults with Eisenmenger syndrome
J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1982 - 1987.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
P. Egermayer, G I. Town, and A. J Peacock
Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension
Thorax, February 1, 1999; 54(2): 161 - 168.
[Full Text]